Cargando…

The causal relationship between sarcopenic obesity factors and benign prostate hyperplasia

BACKGROUND: Both benign prostatic hyperplasia (BPH) and sarcopenic obesity (SO) are common conditions among older adult/adults males. The prevalent lifestyle associated with SO is a significant risk factor for the development of BPH. Therefore, we investigated the causal relationship between SO fact...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rao, Xuezhi, Xu, Zhijie, Zhang, Jingchun, Zhou, Jiaxiang, Huang, Jian, Toh, Zhanhao, Zheng, Ruwen, Zhou, Zhiyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10663947/ https://www.ncbi.nlm.nih.gov/pubmed/38027182 http://dx.doi.org/10.3389/fendo.2023.1290639

Ejemplares similares

Editorial: (Osteo)Sarcopenia & sarcopenic obesity
por: Masiero, Stefano, et al.
Publicado: (2023)

Exposure to Di-2-ethylhexyl Phthalate and Benign Prostatic Hyperplasia, NHANES 2001-2008
por: Yang, Luchen, et al.
Publicado: (2022)

Diabetes and Sarcopenic Obesity: Pathogenesis, Diagnosis, and Treatments
por: Wang, Mina, et al.
Publicado: (2020)

Sarcopenic Obesity in Heart Failure With Preserved Ejection Fraction
por: Kirkman, Danielle L., et al.
Publicado: (2020)

Health Consequences of Sarcopenic Obesity: A Narrative Review
por: Roh, Eun, et al.
Publicado: (2020)

Sarcopenic Obesity in Children and Adolescents: A Systematic Review
por: Zembura, Marcela, et al.
Publicado: (2022)

Editorial: (Osteo)sarcopenia & sarcopenic obesity, volume II
por: Kostoglou-Athanassiou, Ifigenia, et al.
Publicado: (2023)

Reoperation after surgical treatment for benign prostatic hyperplasia: a systematic review
por: He, Weixiang, et al.
Publicado: (2023)

Sarcopenic Obesity in Individuals With Neurodisabilities: The SarcObeNDS Study
por: Dionyssiotis, Yannis, et al.
Publicado: (2022)

Corrigendum: Sarcopenic obesity in children and adolescents: a systematic review
por: Zembura, Marcela, et al.
Publicado: (2023)

Sarcopenic obesity: epidemiology, pathophysiology, cardiovascular disease, mortality, and management
por: Wei, Shibo, et al.
Publicado: (2023)

Association Between Reduced Daily Steps and Sarcopenic Obesity in Treatment-Seeking Adults With Obesity
por: Kreidieh, Dima, et al.
Publicado: (2020)

Exercise Therapy for People With Sarcopenic Obesity: Myokines and Adipokines as Effective Actors
por: Alizadeh Pahlavani, Hamed
Publicado: (2022)

Causal relationship between obesity, lifestyle factors and risk of benign prostatic hyperplasia: a univariable and multivariable Mendelian randomization study
por: Wang, Yong-Bo, et al.
Publicado: (2022)

Upregulated Interleukin 21 Receptor Enhances Proliferation and Epithelial-Mesenchymal Transition Process in Benign Prostatic Hyperplasia
por: Xu, Deqiang, et al.
Publicado: (2019)

Exercise and physical performance in older adults with sarcopenic obesity: A systematic review
por: Ghiotto, Laura, et al.
Publicado: (2022)

Impact of Diabetes Mellitus on Lower Urinary Tract Symptoms in Benign Prostatic Hyperplasia Patients: A Meta-Analysis
por: Xin, Caihong, et al.
Publicado: (2022)

Exploring NCX4040, an Aspirin Derivative, as a Potential Treatment for Benign Prostatic Hyperplasia
por: Shahagadkar, Preksha Vaibhav, et al.
Publicado: (2021)

Indices of sarcopenic obesity are important predictors of finite element analysis-derived bone strength in older adults with obesity
por: Gregori, Giulia, et al.
Publicado: (2023)

Benign Prostatic Hyperplasia
Publicado: (2015)

Why should sarcopenic obesity be included in a routine assessment during weight-management programmes?
por: El Ghoch, Marwan, et al.
Publicado: (2022)

Adiponectin deficiency contributes to the development and progression of benign prostatic hyperplasia in obesity
por: Fu, Shi, et al.
Publicado: (2017)

Genetic causal relationship between age at menarche and benign oesophageal neoplasia identified by a Mendelian randomization study
por: Su, Yani, et al.
Publicado: (2023)

Sarcopenic osteoporosis, sarcopenic obesity, and sarcopenic osteoporotic obesity in the Camargo cohort (Cantabria, Spain)
por: Hernández-Martínez, Paula, et al.
Publicado: (2022)

Testosterone and benign prostatic hyperplasia
por: Jarvis, Thomas R, et al.
Publicado: (2015)

Dynamics of Anthropometric Indices in a Large Paired Cohort With 10 Years of Follow-Up: Paving the Way to Sarcopenic Obesity
por: Santos, Maria-Dolores, et al.
Publicado: (2020)

Worsening Disability and Hospitalization Risk in Sarcopenic Obese and Dynapenic Abdominal Obese: A 5.5 Years Follow-Up Study in Elderly Men and Women
por: Rossi, Andrea P., et al.
Publicado: (2020)

Urinary microbiota in patients with prostate cancer and benign prostatic hyperplasia
por: Yu, Haining, et al.
Publicado: (2015)

Causal relationships of obesity on musculoskeletal chronic pain: A two-sample Mendelian randomization study
por: Chen, Xiaoqing, et al.
Publicado: (2022)

Silodosin in the treatment of benign prostatic hyperplasia
por: Rossi, Maxime, et al.
Publicado: (2010)

Management of benign prostatic hyperplasia with silodosin
por: Yamanishi, Tomonori, et al.
Publicado: (2009)

Pathophysiology of clinical benign prostatic hyperplasia
por: Foo, Keong Tatt
Publicado: (2017)

Epidemiology of clinical benign prostatic hyperplasia
por: Lim, Kok Bin
Publicado: (2017)

Botulinum toxin and benign prostatic hyperplasia
por: Ng, Lay Guat
Publicado: (2018)

Solving the benign prostatic hyperplasia puzzle
por: Foo, Keong Tatt
Publicado: (2016)

Tissue microenvironment and benign prostatic hyperplasia
por: Wei, Xing, et al.
Publicado: (2019)

Relationship of age, prostate-specific antigen, and prostate volume in Indonesian men with benign prostatic hyperplasia
por: Putra, Ida Bagus O.W., et al.
Publicado: (2016)

Relationship between Intravesical Prostatic Protrusion and Postoperative Outcomes in Patients with Benign Prostatic Hyperplasia
por: Lee, Jong Woo, et al.
Publicado: (2012)

Genetically predicted alterations in thyroid function are associated with the risk of benign prostatic disease
por: Huang, Yan, et al.
Publicado: (2023)

Exophytic benign prostatic hyperplasia presenting as a polycystic pelvic mass
por: Xu, Shuang, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1re4753fqpaafuahg5s7cka37n